drugset / Trial / NCT06076668

Dexmedetomidine Infusion Versus Oral Melatonin for Prevention of Intensive Care Delirium

NCT06076668

Unknown 90 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

This study aims to compare the effect of dexmedetomidine infusion and oral melatonin on preventing delirium in intensive care unit (ICU) patients.

Timeline

Start
2023-10-16
Primary completion
2024-10-20
Completion
2024-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Subject Melatonin Small molecule 3 mg Oral

Indications